It has been reported that OPN overexpressed in a variety of cancer cells, contains an RGD domain that has strong affinity for cells overexpressing integrin receptors (αvβ3 and αvβ5) and is often designed for tumor targeting48–50. The gene discussed is SPP1; the disease is cancer.